Initial experience with tissue plasminogen activator in two pediatric oncology patients

Tiffanie Johnson, Joseph D. Tobias

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

With the more frequent use of central venous catheters in children for therapeutic interventions such as the administration of chemotherapy and total parenteral nutrition, there has been an increased recognition of thrombotic complications including thrombotic occlusion, deep venous thrombosis, and superior vena cava syndrome. In the symptomatic child, treatment may be warranted to prevent the sequelae of venous thrombosis including embolic phenomena, secondary bacterial infection, as well as post- thrombotic changes in an extremity. One option for treatment is the use of a thrombolytic agent such as tissue plasminogen activator (TPA). The authors present two children who developed thrombotic complications of central venous devices. TPA successfully resolved the clot and reversed the clinical signs and symptoms of venous obstruction. The literature concerning the use of TPA in pediatric patients, its application in such situations, adverse affects, and dosing regimens are presented.

Original languageEnglish (US)
Pages (from-to)53-58
Number of pages6
JournalJournal of Intensive Care Medicine
Volume15
Issue number1
DOIs
StatePublished - Jan 2000
Externally publishedYes

Fingerprint

Tissue Plasminogen Activator
Pediatrics
Venous Thrombosis
Superior Vena Cava Syndrome
Fibrinolytic Agents
Central Venous Catheters
Total Parenteral Nutrition
Coinfection
Bacterial Infections
Signs and Symptoms
Therapeutics
Extremities
Drug Therapy
Equipment and Supplies

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Initial experience with tissue plasminogen activator in two pediatric oncology patients. / Johnson, Tiffanie; Tobias, Joseph D.

In: Journal of Intensive Care Medicine, Vol. 15, No. 1, 01.2000, p. 53-58.

Research output: Contribution to journalArticle

@article{dbdc6b0044524eba8618633d14e3a138,
title = "Initial experience with tissue plasminogen activator in two pediatric oncology patients",
abstract = "With the more frequent use of central venous catheters in children for therapeutic interventions such as the administration of chemotherapy and total parenteral nutrition, there has been an increased recognition of thrombotic complications including thrombotic occlusion, deep venous thrombosis, and superior vena cava syndrome. In the symptomatic child, treatment may be warranted to prevent the sequelae of venous thrombosis including embolic phenomena, secondary bacterial infection, as well as post- thrombotic changes in an extremity. One option for treatment is the use of a thrombolytic agent such as tissue plasminogen activator (TPA). The authors present two children who developed thrombotic complications of central venous devices. TPA successfully resolved the clot and reversed the clinical signs and symptoms of venous obstruction. The literature concerning the use of TPA in pediatric patients, its application in such situations, adverse affects, and dosing regimens are presented.",
author = "Tiffanie Johnson and Tobias, {Joseph D.}",
year = "2000",
month = "1",
doi = "10.1046/j.1525-1489.2000.00053.x",
language = "English (US)",
volume = "15",
pages = "53--58",
journal = "Journal of Intensive Care Medicine",
issn = "0885-0666",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Initial experience with tissue plasminogen activator in two pediatric oncology patients

AU - Johnson, Tiffanie

AU - Tobias, Joseph D.

PY - 2000/1

Y1 - 2000/1

N2 - With the more frequent use of central venous catheters in children for therapeutic interventions such as the administration of chemotherapy and total parenteral nutrition, there has been an increased recognition of thrombotic complications including thrombotic occlusion, deep venous thrombosis, and superior vena cava syndrome. In the symptomatic child, treatment may be warranted to prevent the sequelae of venous thrombosis including embolic phenomena, secondary bacterial infection, as well as post- thrombotic changes in an extremity. One option for treatment is the use of a thrombolytic agent such as tissue plasminogen activator (TPA). The authors present two children who developed thrombotic complications of central venous devices. TPA successfully resolved the clot and reversed the clinical signs and symptoms of venous obstruction. The literature concerning the use of TPA in pediatric patients, its application in such situations, adverse affects, and dosing regimens are presented.

AB - With the more frequent use of central venous catheters in children for therapeutic interventions such as the administration of chemotherapy and total parenteral nutrition, there has been an increased recognition of thrombotic complications including thrombotic occlusion, deep venous thrombosis, and superior vena cava syndrome. In the symptomatic child, treatment may be warranted to prevent the sequelae of venous thrombosis including embolic phenomena, secondary bacterial infection, as well as post- thrombotic changes in an extremity. One option for treatment is the use of a thrombolytic agent such as tissue plasminogen activator (TPA). The authors present two children who developed thrombotic complications of central venous devices. TPA successfully resolved the clot and reversed the clinical signs and symptoms of venous obstruction. The literature concerning the use of TPA in pediatric patients, its application in such situations, adverse affects, and dosing regimens are presented.

UR - http://www.scopus.com/inward/record.url?scp=0033979216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033979216&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1489.2000.00053.x

DO - 10.1046/j.1525-1489.2000.00053.x

M3 - Article

AN - SCOPUS:0033979216

VL - 15

SP - 53

EP - 58

JO - Journal of Intensive Care Medicine

JF - Journal of Intensive Care Medicine

SN - 0885-0666

IS - 1

ER -